Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications
HR-pQCT measures of bone in autosomal dominant osteopetrosis highly correlate with fractures and inversely correlate with bone resorption markers.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Published: November 25, 2025
Can transient neonatal osteosclerosis be differentiated from malignant infantile osteopetrosis?
Journal: Bone reports
Published: June 30, 2025
Fractures are Highly Correlated with Bone Density and Inversely Correlated with Bone Turnover Markers in Autosomal Dominant Osteopetrosis.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Published: June 09, 2025
Fractures are highly correlated with bone density and inversely correlated with bone turnover markers in autosomal dominant osteopetrosis.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Published: June 09, 2025
Effect of Allele-Specific Clcn7G213R siRNA Delivered Via a Novel Nanocarrier on Bone Phenotypes in ADO2 Mice on 129S Background.
Journal: Calcified tissue international
Published: February 09, 2024
Patient-Reported Outcomes in Autosomal Dominant Osteopetrosis: Findings From the Osteopetrosis Registry Study.
Journal: The Journal of clinical endocrinology and metabolism
Published: November 30, 2023
The PDE4 Inhibitors Roflumilast and Rolipram Rescue ADO2 Osteoclast Resorption Dysfunction.
Journal: Calcified tissue international
Published: September 04, 2023
Effect of Roflumilast, a Selective PDE4 Inhibitor, on Bone Phenotypes in ADO2 Mice.
Journal: Calcified tissue international
Published: August 29, 2023
Autosomal Dominant Osteopetrosis (ADO) Caused by a Missense Variant in the TCIRG1 Gene.
Journal: The Journal of clinical endocrinology and metabolism
Published: August 04, 2023
Case 18-2022: A 29-Year-Old Woman with Recurrent Fractures.
Journal: The New England journal of medicine
Published: June 15, 2022
Hyperphosphatemic Tumoral Calcinosis With Pemigatinib Use.
Journal: AACE clinical case reports
Published: April 27, 2022
Last Updated: 09/26/2026